180 related articles for article (PubMed ID: 12885349)
1. Ex vivo gene therapy for skeletal regeneration in cranial defects compromised by postoperative radiotherapy.
Nussenbaum B; Rutherford RB; Teknos TN; Dornfeld KJ; Krebsbach PH
Hum Gene Ther; 2003 Jul; 14(11):1107-15. PubMed ID: 12885349
[TBL] [Abstract][Full Text] [Related]
2. Bone regeneration in cranial defects previously treated with radiation.
Nussenbaum B; Rutherford RB; Krebsbach PH
Laryngoscope; 2005 Jul; 115(7):1170-7. PubMed ID: 15995502
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo.
Krebsbach PH; Gu K; Franceschi RT; Rutherford RB
Hum Gene Ther; 2000 May; 11(8):1201-10. PubMed ID: 10834621
[TBL] [Abstract][Full Text] [Related]
4. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes.
Park J; Ries J; Gelse K; Kloss F; von der Mark K; Wiltfang J; Neukam FW; Schneider H
Gene Ther; 2003 Jul; 10(13):1089-98. PubMed ID: 12808439
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy approaches for bone regeneration.
Franceschi RT; Yang S; Rutherford RB; Krebsbach PH; Zhao M; Wang D
Cells Tissues Organs; 2004; 176(1-3):95-108. PubMed ID: 14745239
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration.
Koh JT; Zhao Z; Wang Z; Lewis IS; Krebsbach PH; Franceschi RT
J Dent Res; 2008 Sep; 87(9):845-9. PubMed ID: 18719211
[TBL] [Abstract][Full Text] [Related]
7. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
8. In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model.
Blum JS; Barry MA; Mikos AG; Jansen JA
Hum Gene Ther; 2003 Dec; 14(18):1689-701. PubMed ID: 14670121
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo gene therapy with stromal cells transduced with a retroviral vector containing the BMP4 gene completely heals critical size calvarial defect in rats.
Gysin R; Wergedal JE; Sheng MH; Kasukawa Y; Miyakoshi N; Chen ST; Peng H; Lau KH; Mohan S; Baylink DJ
Gene Ther; 2002 Aug; 9(15):991-9. PubMed ID: 12101429
[TBL] [Abstract][Full Text] [Related]
10. Localized viral vector delivery to enhance in situ regenerative gene therapy.
Hu WW; Wang Z; Hollister SJ; Krebsbach PH
Gene Ther; 2007 Jun; 14(11):891-901. PubMed ID: 17344901
[TBL] [Abstract][Full Text] [Related]
11. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice.
Lee JY; Musgrave D; Pelinkovic D; Fukushima K; Cummins J; Usas A; Robbins P; Fu FH; Huard J
J Bone Joint Surg Am; 2001 Jul; 83(7):1032-9. PubMed ID: 11451972
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo bone morphogenetic protein-2 gene delivery using gingival fibroblasts promotes bone regeneration in rats.
Shin JH; Kim KH; Kim SH; Koo KT; Kim TI; Seol YJ; Ku Y; Rhyu IC; Chung CP; Lee YM
J Clin Periodontol; 2010 Mar; 37(3):305-11. PubMed ID: 20041973
[TBL] [Abstract][Full Text] [Related]
13. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats.
Lieberman JR; Daluiski A; Stevenson S; Wu L; McAllister P; Lee YP; Kabo JM; Finerman GA; Berk AJ; Witte ON
J Bone Joint Surg Am; 1999 Jul; 81(7):905-17. PubMed ID: 10428121
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy of bone morphogenetic protein for periodontal tissue engineering.
Jin QM; Anusaksathien O; Webb SA; Rutherford RB; Giannobile WV
J Periodontol; 2003 Feb; 74(2):202-13. PubMed ID: 12666709
[TBL] [Abstract][Full Text] [Related]
15. Large-scale bicortical skull bone regeneration using ex vivo replication-defective adenoviral-mediated bone morphogenetic protein-2 gene-transferred bone marrow stromal cells and composite biomaterials.
Chang SC; Lin TM; Chung HY; Chen PK; Lin FH; Lou J; Jeng LB
Neurosurgery; 2009 Dec; 65(6 Suppl):75-81; discussion 81-3. PubMed ID: 19935005
[TBL] [Abstract][Full Text] [Related]
16. The effect of BMP-7 gene activated muscle tissue implants on the repair of large segmental bone defects.
Betz VM; Betz OB; Rosin T; Keller A; Thirion C; Salomon M; Manthey S; Augat P; Jansson V; Müller PE; Rammelt S; Zwipp H
Injury; 2015 Dec; 46(12):2351-8. PubMed ID: 26454628
[TBL] [Abstract][Full Text] [Related]
17. An expedited approach for sustained delivery of bone morphogenetic protein-7 to bone defects using gene activated fragments of subcutaneous fat.
Betz VM; Betz OB; Rosin T; Keller A; Thirion C; Salomon M; Manthey S; Augat P; Jansson V; Müller PE; Rammelt S; Zwipp H
J Gene Med; 2016 Aug; 18(8):199-207. PubMed ID: 27373764
[TBL] [Abstract][Full Text] [Related]
18. Noggin improves bone healing elicited by muscle stem cells expressing inducible BMP4.
Peng H; Usas A; Hannallah D; Olshanski A; Cooper GM; Huard J
Mol Ther; 2005 Aug; 12(2):239-46. PubMed ID: 16043095
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo.
Rutherford RB; Moalli M; Franceschi RT; Wang D; Gu K; Krebsbach PH
Tissue Eng; 2002 Jul; 8(3):441-52. PubMed ID: 12167230
[TBL] [Abstract][Full Text] [Related]
20. Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects.
Betz OB; Betz VM; Nazarian A; Egermann M; Gerstenfeld LC; Einhorn TA; Vrahas MS; Bouxsein ML; Evans CH
Gene Ther; 2007 Jul; 14(13):1039-44. PubMed ID: 17460719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
